Wine Eytan, Aloi Marina, Van Biervliet Stephanie, Bronsky Jiri, di Carpi Javier Martín, Gasparetto Marco, Gianolio Laura, Gordon Hannah, Hojsak Iva, Hudson Alexandra S, Hussey Séamus, van Limbergen Johan, Miele Erasmo, Norsa Lorenzo, Olén Ola, Pellino Gianluca, van Rheenen Patrick, de Ridder Lissy, Russell Richard K, Shouval Dror S, Trindade Eunice, Turner Dan, Wilson David C, Yerushalmy Feler Anat, Assa Amit
Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
University of Toronto, Toronto, Ontario, Canada.
J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):765-815. doi: 10.1002/jpn3.70097. Epub 2025 Jul 18.
Despite advances in the management of ambulatory paediatric ulcerative colitis (UC), challenges remain as many patients are refractory to therapy and some require colectomy. The aim of these guidelines is to provide an update on optimal care for UC through detailed recommendations and practice points.
These guidelines are an update to those published in 2018 and are a joint effort of the Paediatric IBD Porto group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation. An extensive literature search with subsequent evidence appraisal using the Oxford methodology was performed, followed by three online voting sessions and a consensus face-to-face meeting. Thirty-nine recommendations and 77 practice points were endorsed by the 25 experts with at least an 84% consensus rate.
Robust evidence-based recommendations and detailed practice points are provided. In addition to reemphasising and updating the role of more 'traditional' UC therapies, these guidelines outline optimising the use of antitumour necrosis factor therapies and integrating newer biologics and small molecules, as well as supportive therapy, to improve outcomes and provide an updated management algorithm. Measurement and monitoring tools and decision aids are provided, and additional aspects, including nutritional support, extraintestinal manifestations, pouchitis, inflammatory bowel disease-unclassified and patient support, are discussed. Some aspects, including surgery and thromboprophylaxis, are covered in the acute severe UC guidelines.
These guidelines serve as an aid in managing children with UC through a combination of evidence-based recommendations and more practical practice points in the ambulatory setting.
尽管在门诊儿童溃疡性结肠炎(UC)的管理方面取得了进展,但挑战依然存在,因为许多患者对治疗无效,一些患者需要进行结肠切除术。这些指南的目的是通过详细的建议和实践要点,提供关于UC最佳治疗的最新信息。
这些指南是对2018年发布的指南的更新,是欧洲儿科胃肠病学、肝病学和营养学会的儿科炎症性肠病波尔图小组与欧洲克罗恩病和结肠炎组织共同努力的结果。使用牛津方法进行了广泛的文献检索及后续证据评估,随后进行了三次在线投票会议和一次面对面的共识会议。25位专家认可了39项建议和77个实践要点,共识率至少为84%。
提供了基于有力证据的建议和详细的实践要点。除了再次强调和更新更“传统”的UC治疗方法的作用外,这些指南还概述了优化抗肿瘤坏死因子治疗的使用,整合新型生物制剂和小分子药物以及支持性治疗,以改善治疗效果并提供最新的管理算法。提供了测量和监测工具以及决策辅助工具,并讨论了其他方面,包括营养支持、肠外表现、袋炎、炎症性肠病未分类和患者支持。急性重症UC指南涵盖了一些方面,包括手术和血栓预防。
这些指南有助于在门诊环境中通过结合基于证据的建议和更实用的实践要点来管理患有UC的儿童。